kicks off in Riyadh.
The Saudi Obesity Society organized, through the feature of virtual and virtual conferences, the third Saudi International Conference on Obesity under the slogan (A Paradigm Shift in Obesity Management).. The conference constituted a scientific platform to discuss the challenges of high risks of Covid 19 disease and the correlation between it and obesity and overweight, bearing in mind the Obesity is a cause of many chronic diseases.. During the conference, which brought together a group of doctors from several specialties, Saudi and international speakers and senior figures from the Saudi Ministry of Health, the latest research and scientific studies in the field of obesity were reviewed.
The conference began with an introduction by Dr. Saud Al-Safiri, an endocrinologist at King Abdulaziz University, on obesity as a chronic disease resulting from several causes, including genetic, environmental and societal.
Dr. Abdul Rahman Al-Sheikh said that the Kingdom is still the focus of attention in the fight against obesity, as many efforts are being made in this context by focusing on important axes that include raising awareness of the dangers of obesity, enhancing competencies, and using the correct and approved treatments, to make a difference in the fight against obesity.. The Sheikh pointed out to The Kingdom of Saudi Arabia is at the forefront of countries authorizing the use of new drugs to treat adolescent obesity.
For his part, Dr. Khaled Al-Omari reported that there is a correlation between obesity and the Corona virus, noting what health studies revealed about the effects of the Corona virus, that more than half of those who feel severely ill as a result of infection with the virus suffer from obesity, and that about 40 percent of them are under the age of sixty.
The conference activities witnessed many scientific lectures, presentations and interactive workshops that focused on the most prominent issues in this field, including “Obesity, the Tsunami of the Century”, “Why Obesity is a Disease”, “Obesity as the Hidden Economic Burden”, and “The Kingdom’s Vision in Combating Obesity” The “Role of Obesity in Catalytic Heart Diseases”, “Obesity and Children: A Gateway to Type II Diseases”, “The Correlation between Obesity and Corona”, “Diet Plans”, “The Role of Nutrition in Obesity Management”, and “Obesity” Adolescents”, “The Role of Pharmacists in Obesity Management” and other issues.
Meanwhile, Professor Karel Le Roux highlighted the importance of anti-obesity drugs in the journey of managing this disease, noting their important role in intervening through lifestyle and in obesity surgery, noting that anti-obesity drugs available in the Saudi market not only reduce the patient''s weight but also It enhances the general health of a person by helping to improve the lifestyle, reduce the incidence of many diseases and control many comorbid conditions.
As for Dr. Abdul Rahman Al-Triki, he was exposed to the important role played by the community pharmacist in helping the patient to reach the required weight, and his role in supporting, guiding and educating the patient, stating that pharmacists reflect the importance of managing obesity in the community as a great economic burden, although it was assumed that It does not have an effect of this magnitude.
On the other hand, Dr. Hana Abdul Karim pointed to the effective and hoped-for role of the Kingdom''s Vision 2030 by facilitating access to a tight management of obesity.
The conference concluded its activities with a series of questions and answers between doctors and specialists, in order to reach a deeper understanding of solving obesity problems and related diseases, especially at the time of the Corona pandemic.
